摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

prop-2-enyl (2S,3R)-3-[(2S,3R,4R,5R,6R)-4-[(2S,4'S,4aS,5R,5'R,6'R,7R,8R,8aS)-5'-acetamido-3-oxo-4',8-bis(phenylmethoxy)-5-(phenylmethoxymethyl)-6'-[(1S,2R)-1,2,3-tris(phenylmethoxy)propyl]spiro[5,7,8,8a-tetrahydro-4aH-pyrano[3,4-b][1,4]dioxine-2,2'-oxane]-7-yl]oxy-3-azido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanoate | 227286-37-5

中文名称
——
中文别名
——
英文名称
prop-2-enyl (2S,3R)-3-[(2S,3R,4R,5R,6R)-4-[(2S,4'S,4aS,5R,5'R,6'R,7R,8R,8aS)-5'-acetamido-3-oxo-4',8-bis(phenylmethoxy)-5-(phenylmethoxymethyl)-6'-[(1S,2R)-1,2,3-tris(phenylmethoxy)propyl]spiro[5,7,8,8a-tetrahydro-4aH-pyrano[3,4-b][1,4]dioxine-2,2'-oxane]-7-yl]oxy-3-azido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanoate
英文别名
——
prop-2-enyl (2S,3R)-3-[(2S,3R,4R,5R,6R)-4-[(2S,4'S,4aS,5R,5'R,6'R,7R,8R,8aS)-5'-acetamido-3-oxo-4',8-bis(phenylmethoxy)-5-(phenylmethoxymethyl)-6'-[(1S,2R)-1,2,3-tris(phenylmethoxy)propyl]spiro[5,7,8,8a-tetrahydro-4aH-pyrano[3,4-b][1,4]dioxine-2,2'-oxane]-7-yl]oxy-3-azido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanoate化学式
CAS
227286-37-5
化学式
C87H93N5O21
mdl
——
分子量
1544.72
InChiKey
GMPQOZKONRJYSS-URBACINWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    11.2
  • 重原子数:
    113
  • 可旋转键数:
    38
  • 环数:
    13.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    286
  • 氢给体数:
    4
  • 氢受体数:
    23

反应信息

  • 作为反应物:
    描述:
    苯甲醛二甲缩醛prop-2-enyl (2S,3R)-3-[(2S,3R,4R,5R,6R)-4-[(2S,4'S,4aS,5R,5'R,6'R,7R,8R,8aS)-5'-acetamido-3-oxo-4',8-bis(phenylmethoxy)-5-(phenylmethoxymethyl)-6'-[(1S,2R)-1,2,3-tris(phenylmethoxy)propyl]spiro[5,7,8,8a-tetrahydro-4aH-pyrano[3,4-b][1,4]dioxine-2,2'-oxane]-7-yl]oxy-3-azido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanoate对甲苯磺酸 作用下, 以 乙腈 为溶剂, 反应 0.25h, 以86%的产率得到N-(9-fluorenylmethoxycarbonyl)-O-[(5-acetamido-4,7,8,9-tetra-O-benzyl-3,5-dideoxy-D-glycero-α-D-galacto-2-nonulopyranosylonic acid)-(2->3)-(2,6-di-O-benzyl-β-D-galactopyranosyl)-(1->3)-2-azido-4,6-O-benzylidene-2-deoxy-α-D-galactopyranosyl-...]...
    参考文献:
    名称:
    带有连续唾液酸-T抗原的人糖蛋白AM的糖肽的固相合成。
    摘要:
    使用在弱酸不稳定的树脂上高效糖基化的氨基酸结构单元,可以完成带有连续唾液酸-T抗原的人糖蛋白AM的N端糖五肽的Fmoc固相合成。将苄基化的糖肽用TFA中的TMSOTf-硫代茴香醚处理,然后用NaHCO 3水溶液处理,以良好的产率提供脱保护的糖肽。
    DOI:
    10.1016/s0008-6215(00)00235-4
  • 作为产物:
    描述:
    prop-2-enyl (2S,3R)-3-[(2S,3R,4R,5R,6R)-4-[(2S,4'S,4aS,5R,5'R,6'R,7R,8R,8aS)-5'-acetamido-3-oxo-4',8-bis(phenylmethoxy)-5-(phenylmethoxymethyl)-6'-[(1S,2R)-1,2,3-tris(phenylmethoxy)propyl]spiro[5,7,8,8a-tetrahydro-4aH-pyrano[3,4-b][1,4]dioxine-2,2'-oxane]-7-yl]oxy-3-azido-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-hydroxyoxan-2-yl]oxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanoate 在 三氟乙酸 作用下, 以 二氯甲烷 为溶剂, 以90%的产率得到prop-2-enyl (2S,3R)-3-[(2S,3R,4R,5R,6R)-4-[(2S,4'S,4aS,5R,5'R,6'R,7R,8R,8aS)-5'-acetamido-3-oxo-4',8-bis(phenylmethoxy)-5-(phenylmethoxymethyl)-6'-[(1S,2R)-1,2,3-tris(phenylmethoxy)propyl]spiro[5,7,8,8a-tetrahydro-4aH-pyrano[3,4-b][1,4]dioxine-2,2'-oxane]-7-yl]oxy-3-azido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanoate
    参考文献:
    名称:
    The first total synthesis of the core class II disialylated hexasaccharide as a building block for glycopeptide synthesis
    摘要:
    The first total synthesis of the protected core class II sialylated glycosyl-Thr hexasaccharide (3), utilizing suitably protected building blocks 4, 5, 7 and 8 was accomplished. (C) 1999 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4039(99)00605-x
点击查看最新优质反应信息

文献信息

  • Solid-phase synthesis of the glycopeptide of human glycophorin AM bearing the consecutive sialyl-T antigen
    作者:Sumie Ando、Yuko Nakahara、Yukishige Ito、Tomoya Ogawa、Yoshiaki Nakahara
    DOI:10.1016/s0008-6215(00)00235-4
    日期:2000.12
    Fmoc solid-phase synthesis of the N-terminal glycopentapeptide of human glycophorin AM, bearing the consecutive sialyl-T antigen, was accomplished using glycosylated amino acid building blocks on a weakly acid-labile resin with high efficiency. The benzylated glycopeptide was treated with TMSOTf-thioanisole in TFA and then with aq NaHCO3 to afford the deprotected glycopeptide in good yield.
    使用在弱酸不稳定的树脂上高效糖基化的氨基酸结构单元,可以完成带有连续唾液酸-T抗原的人糖蛋白AM的N端糖五肽的Fmoc固相合成。将苄基化的糖肽用TFA中的TMSOTf-硫代茴香醚处理,然后用NaHCO 3水溶液处理,以良好的产率提供脱保护的糖肽。
  • The first total synthesis of the core class II disialylated hexasaccharide as a building block for glycopeptide synthesis
    作者:Latika Singh、Yuko Nakahara、Yukishige Ito、Yoshiaki Nakahara
    DOI:10.1016/s0040-4039(99)00605-x
    日期:1999.5
    The first total synthesis of the protected core class II sialylated glycosyl-Thr hexasaccharide (3), utilizing suitably protected building blocks 4, 5, 7 and 8 was accomplished. (C) 1999 Elsevier Science Ltd. All rights reserved.
查看更多

同类化合物

霉酚酸苯酚beta-D-葡糖苷 阜孢霉素B 阜孢杀菌素 蔗糖棕榈酸酯 蔗糖四异硬脂酸酯 蔗糖七月桂酸酯 药喇叭(IPOMOEAPURGA)树脂 硫脂I 石斛碱;青藤碱 环戊羧酸,1-氨基-2-甲基-,(1R,2S)-rel- 海藻糖 6,6'-二山嵛酸酯 木松香II 木松香I 单岩藻糖基乳糖-N-四糖 二唾液酸乳-N-四糖 乳糖醛酸 乙醋化己二酸双淀粉 中文名称暂缺 β-D-呋喃果糖基-α-D-吡喃葡萄苷二硬脂酸酯 Β-D-呋喃果糖基-Α-D-吡喃葡糖苷十二酸双酯 alpha-D-吡喃葡萄糖基-alpha-D-吡喃葡萄糖苷 6-(3-羟基-2-十四烷基十八烷酸酯) [(3aR,5R,5aR,8aS,8bR)-2,2,7,7-四甲基四氢-3aH-二[1,3]二噁唑并[4,5-b:4',5'-d]吡喃-5-基]甲基丁酸酯(non-preferredname) [(2R,3S,4S,5R,6R)-6-[(2R,3R,4S,5S,6R)-6-(十六烷酰氧基甲基)-3,4,5-三羟基四氢吡喃-2-基]氧基-3,4,5-三羟基四氢吡喃-2-基]甲基十六烷酸酯 [(2R,3S,4S,5R)-3,4-二羟基-2,5-二(羟基甲基)四氢呋喃-2-基][(2R,3S,4S,5R,6S)-3,4,5,6-四羟基四氢吡喃-2-基]甲基2-甲基-4-(2-甲基癸-1-烯-4-基)己二酸酯 [(2R,3R,4S,5R,6R)-6-[[(1R,2R,3R,4R,6R)-2,3-二羟基-5,8-二氧杂双环[4.2.0]辛烷-4-基]氧基]-3,4,5-三羟基四氢吡喃-2-基]甲基3-羟基-2-十四烷基十八烷酸酯 N-乙酰基-硫代胞壁酰-丙氨酰-异谷氨酰胺 N-(O-alpha-D-甘露糖基-(1-3)-O-(O-alpha-D-甘露糖基-(1->3)-O-(alpha-D-甘露糖基-(1-6))-alpha-D-甘露糖基-(1-6))-O-beta-D-甘露糖基-(1->4)-O-2-(乙酰氨基)-2-脱氧-beta-D-吡喃葡萄糖基-(1->4)-2-(乙酰氨基)-2-脱氧-beta-D-吡喃葡萄糖基)-L-天冬氨酰胺 L-缬氨酰-L-丙氨酰-L-缬氨酰甘氨酰-L-α-谷氨酰-L-α-谷氨酰-L-脯氨酰甘氨酰-L-脯氨酰-N~5~-(二氨基甲亚基)-L-鸟氨酸酰胺 D-甘露糖基-(1-6)-D-甘露糖基-(1-4)-2-乙酰氨基-2-脱氧-D-吡喃葡萄糖基-(1-4)-2-乙酰氨基-1-N-(4'-L-天冬氨酰)-2-脱氧-beta-D-吡喃葡萄糖基胺 D-(+)-海藻糖6-单油酸酯 9,10-二氯-2,6-二甲基蒽 8-甲氧基羰基辛基2-O-(aL-呋喃基呋喃糖基)-3-O-(aD-吡喃半乳糖基)-bD-吡喃半乳糖苷 6-山慈菇甙A 6-O-alpha-D-吡喃半乳糖基-D-葡萄糖酸 6,6'-二((2R,3R)-3-羟基-2-十四烷基十八烷酸酯)-海藻糖 4H-吡咯并[3,2,1-脱]蝶啶,5,6-二氢-4,5-二甲基-(9CI) 4-嘧啶甲腈,2-苯基- 4-[[(2R)-2-羟基-3,3-二甲基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基丁酰基]氨基]丁酸 4-[6-(1,2-二羟基乙基)-3,4,5-三羟基-四氢吡喃-2-基]氧基-2,3,5-三羟基-7,8-二氧代-辛酸 3-O-棕榈酰-beta-D-呋喃果糖基2,3-二-O-棕榈酰-alpha-D-吡喃葡萄糖苷 3-(6H-苯并[b][1,5]苯并噁噻庚英-6-基)丙基-二甲基-铵2-羟基-2-羰基-乙酸酯 2-脱氧-3-O-[(3R)-3-羟基十四烷酰基]-2-{[(3R)-3-羟基十四烷酰基]氨基}-1-O-膦酰-alpha-D-吡喃葡萄糖 2-氨基-6-[[3,5,6-三羟基-2-氧代-4-[3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基己基]氨基]己酸 2-氨基-4-氧代-4-[[3,4,5-三羟基-6-[[3,4,5-三羟基-6-[[3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基甲基]四氢吡喃-2-基]氧基甲基]四氢吡喃-2-基]氨基]丁酸 2-N-(羧基丙基氨基)-2-脱氧葡萄吡喃糖 2,6-二甲基-6-(3-O-(beta-吡喃葡萄糖基)-4-O-(2-甲基丁酰基)alpha-阿拉伯吡喃糖基氧基)-2,7-辛二烯酸 1-二甲胺基萘-5-磺酰-甘氨酰-赖氨酰-酪氨酰-丙氨酰-脯氨酰-色氨酰-缬氨酸 1-O,2-O,3-O-三(3-硝基丙酰基)-alpha-D-吡喃葡萄糖 1,1-O-(4,6-二羟基-1,2-亚苯亚甲基)-4-O-[6-O-(1-氧代-2,4-癸二烯基)-beta-D-吡喃半乳糖基]-alpha-D-吡喃葡萄糖3-(7-羟基-8,14-二甲基十六碳-2,4,8,10-四烯酸酯) (Z,Z)-甲基-D-吡喃葡糖苷-2,6-二油酸酯